Lampera, Baby Girl .
HRN: 22-56-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/12/2023
02/18/2023
IV
16mg
OD
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes